Article Text

Download PDFPDF
Improved antisaccade performance in schizophrenia with risperidone
  1. S B Hutton
  1. Department of Experimental Psychology, University of Sussex, Falmer, Brighton BN1 9QG, UK
  1. Correspondence to: 
 Dr S B Hutton; 

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Atypical treatment improves cognitive function

Several recent studies have suggested that atypical antipsychotic medications such as risperidone can ameliorate certain cognitive deficits associated with schizophrenia.1 Such findings have important implications, as cognitive impairment is a significant predictor of both social and occupational functioning in schizophrenia. In this issue, Burke and Reveley (pp 449–454)2 show that patients treated with the atypical antipsychotic risperidone make fewer antisaccade errors than when they are treated …

View Full Text